Allogeneic hematopoietic cell transplantation
Subjects are permitted to undergo allo-HCT at any time after salvage therapy. Quizartinib should be discontinued at least 7 days before the start of a conditioning regimen. Maintenance therapy may be given starting the earliest at day 30 and the latest at day 100 after transplant according to initial randomization.